NADPH oxidase mediates synergistic effects of IL-17 and TNF-α on CXCL1 expression by epithelial cells after lung ischemia-reperfusion
- 1 January 2014
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 306 (1) , L69-L79
Abstract
Ischemia-reperfusion (I/R) injury leads to increased mortality and morbidity in lung transplant patients. Lung I/R injury involves inflammation contributed by innate immune responses. IL-17 and TNF-α, from iNKT cells and alveolar macrophages, respectively, contribute importantly to lung I/R injury. This study tests the hypothesis that IL-17 and TNF-α synergistically mediate CXCL1 (a potent neutrophil chemokine) production by alveolar type II epithelial (ATII) cells via an NADPH oxidase-dependent mechanism during lung I/R. Using a hilar clamp model, wild-type and p47phox−/−(NADPH oxidase-deficient) mice underwent left lung I/R, with or without recombinant IL-17 and/or TNF-α treatment. Wild-type mice undergoing I/R treated with combined IL-17 and TNF-α had significantly enhanced lung dysfunction, edema, CXCL1 production, and neutrophil infiltration compared with treatment with IL-17 or TNF-α alone. However, p47phox−/−mice had significantly less pulmonary dysfunction, CXCL1 production, and lung injury after I/R that was not enhanced by combined IL-17-TNF-α treatment. Moreover, in an acute in vitro hypoxia-reoxygenation model, murine ATII cells showed a multifold synergistic increase in CXCL1 expression after combined IL-17-TNF-α treatment compared with treatment with either cytokine alone, which was significantly attenuated by an NADPH oxidase inhibitor. Conditioned media transfer from hypoxia-reoxygenation-exposed iNKT cells and macrophages, major sources of IL-17 and TNF-α, respectively, to ATII cells significantly enhanced CXCL1 production, which was blocked by NADPH oxidase inhibitor. These results demonstrate that IL-17 and TNF-α synergistically mediate CXCL1 production by ATII cells after I/R, via an NADPH oxidase-dependent mechanism, to induce neutrophil infiltration and lung I/R injury.Keywords
This publication has 45 references indexed in Scilit:
- IL-17 and TNF-α Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial ActivationThe Journal of Immunology, 2012
- Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)Nature Immunology, 2011
- Natural Killer T Cell–derived IL-17 Mediates Lung Ischemia–Reperfusion InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in diseaseImmunology, 2010
- Mechanisms and Function of DUOX in Epithelia of the LungAntioxidants & Redox Signaling, 2009
- Overexpression of HO-1 Protects against TNF-α-Mediated Airway Inflammation by Down-Regulation of TNFR1-Dependent Oxidative StressThe American Journal of Pathology, 2009
- NADPH Oxidase in Bone Marrow–Derived Cells Mediates Pulmonary Ischemia-Reperfusion InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- CD4+ T lymphocytes mediate acute pulmonary ischemia–reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Apocynin: Molecular AptitudesMediators of Inflammation, 2008
- Lung ischemia–reperfusion injury: implications of oxidative stress and platelet–arteriolar wall interactionsArchives of Physiology and Biochemistry, 2007